Growth Metrics

Integra Lifesciences Holdings (IART) Net Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 26.45%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.45%
Dec 31, 2025 26.38%
Sep 30, 2025 -41.55%
Jun 30, 2025 -39.14%
Mar 31, 2025 51.46%
Dec 31, 2024 -2.40%
Sep 30, 2024 -28.12%
Jun 30, 2024 -198.63%
Mar 31, 2024 101.84%
Dec 31, 2023 -27.69%
Sep 30, 2023 -44.61%
Jun 30, 2023 49.09%
Mar 31, 2023 -43.11%
Dec 31, 2022 -71.08%
Sep 30, 2022 27.49%
Jun 30, 2022 39.68%
Mar 31, 2022 -94.96%
Dec 31, 2021 38.11%
Sep 30, 2021 48.83%
Jun 30, 2021 -130.00%
Mar 31, 2021 -86.99%
Dec 31, 2020 30.31%
Sep 30, 2020 -54.85%
Jun 30, 2020 -70.79%
Mar 31, 2020 98.02%
Dec 31, 2019 -150.85%
Sep 30, 2019 21.59%
Jun 30, 2019 17.65%
Mar 31, 2019 -12.28%
Dec 31, 2018 -30.61%
Sep 30, 2018 34.93%
Jun 30, 2018 -72.26%
Mar 31, 2018 -10.32%
Dec 31, 2017 -52.39%
Sep 30, 2017 229.05%
Jun 30, 2017 45.07%
Mar 31, 2017 36.93%
Dec 31, 2016 -28.72%
Sep 30, 2016 4.81%
Jun 30, 2016 9.87%
Mar 31, 2016 97.20%
Dec 31, 2015 0.46%
Sep 30, 2015 -44.99%
Jun 30, 2015 54.02%
Mar 31, 2015 33.08%
Dec 31, 2014 -121.65%
Sep 30, 2014 34.63%
Jun 30, 2014 -36.71%
Mar 31, 2014 31.58%
Dec 31, 2013 -48.85%
Sep 30, 2013 45.48%
Jun 30, 2013 -31.29%
Mar 31, 2013 -31.36%
Dec 31, 2012 3.08%
Sep 30, 2012 50.45%